TimeMagazine 
Living through the COVID-19 pandemic is hard. TIME’s advice column is here to help. Trying to decide if that dinner party is safe to attend? Fighting through your quarantine fatigue? Our health reporters will consult experts who can help find a safe and practical solution. Send us your pandemic dilemmas at [email protected], and we will … Read more
A bipartisan congressional investigation released Wednesday found that key players in the nation’s opioid industry have spent $65 million since 1997 funding nonprofits that advocate treating pain with medications, a strategy intended to boost the sale of prescription painkillers. The report from Sens. Chuck Grassley of Iowa and Ron Wyden of Oregon found the contributions … Read more
Welcome to COVID Questions, TIME’s new advice column. We’re trying to make living through the pandemic a little easier, with expert-backed answers to your toughest coronavirus-related dilemmas. While we can’t and don’t offer medical advice—those questions should go to your doctor—we hope this column will help you sort through this stressful and confusing time. Got … Read more
Just before 9:30 a.m. on Monday, Sandra Lindsay, an intensive care nurse at Long Island Jewish Medical Center in Queens, New York, became one of the first people to get vaccinated against COVID-19. The jab was the highly anticipated start of what public health experts hope is a nationwide wave of vaccinations that will signal … Read more
More than 300,000 people in the U.S. have died from COVID-19 as of today—a sobering figure under any circumstance, but particularly given the speed at which the the virus is killing more people. In the past week alone, nearly 17,000 people in the U.S. have died of COVID-19. And with hundreds of thousands of new … Read more
In mid-July, the U.S. federal government made an agreement with Pfizer, one of several pharmaceutical companies working to develop a COVID-19 vaccine. The $1.95 billion deal would finance the production and nationwide delivery of 100 million doses of the vaccine, should it be approved by the U.S. Food and Drug Administration. That approval came on … Read more
In the early weeks of the U.S. COVID-19 outbreak this spring, technologists pushed forward an idea to help bring the spread of the new virus under control: smartphones could notify users who had potentially been exposed to others with COVID-19, transforming millions of devices into the world’s most efficient army of public health contact tracers. … Read more
Seven months of strategizing, $18 billion in funding and it’s all come down to this. Now that scientists at the Food and Drug Administration (FDA) have authorized Pfizer/BioNTech’s COVID-19 vaccine, the U.S. government has cleared the way for the distribution of 2.9 million doses to the American public. It’s just the first round of shipments … Read more
With the U.S. setting a new, devastating record of more than 3,000 people dead from COVID-19 in a single day this week, American women say they’re planning on social distancing this holiday season. Men, on the other hand, say they are getting ready for New Year’s parties. Those are some of the findings of a … Read more
Late in the evening on Dec. 11, the U.S. Food and Drug Administration (FDA) authorized the first COVID-19 vaccine for use in the country. The emergency use authorization means that doses of the vaccine—made by Pfizer/BioNTech—can be shipped at any time; certain Americans could be vaccinated as soon as next week. In a statement, FDA … Read more